why choose us

First received: October 28, 2022

Clinical Trial: Dronabinol for Agitation in Dementia Crossover Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Dementia Moderate

Study Type: INTERVENTIONAL


Official Title: Single-site, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Dronabinol for the Treatment of Agitation in Outpatient With Dementia

Brief Summary: The goal of this clinical trial is to study the effects of dronabinol in US Veterans with agitation related to moderate to severe dementia.The main goals of the study are:To evaluate the efficacy of dronabinol for the treatment of agitation in moderate to severe dementia compared to placeboTo evaluate the safety of dronabinol in the treatment of agitation in moderate to severe dementia compared to placeboFifty (50) subjects will be given either dronabinol or placebo for 8 weeks.All subjects will then undergo a…

Read more